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The clinically important Rh blood group system is complex, consisting of multiple distinct
antigens. Despite clinical recognition for over 50 years, the Rh blood group antigens have
remained poorly understood on a molecular level until the recent identification and characteriza-
tion of the "Rh polypeptides," the core structural proteins of the Rh antigens. This group of
erythrocyte membrane proteins of molecular weight 30,000-35,000 daltons was first recognized
by employing Rh-specific antibodies to immunoprecipitate radiolabeled components of erythro-
cyte membranes. By using antibodies specific for the Rh D, c, and E antigens, a series of highly
related non-identical proteins were immunoprecipitated, indicating that the Rh antigens are
composed of multiple related proteins. The Rh polypeptides have been purified and characterized,
and they were found to have several unusual biochemical characteristics. The Rh polypeptides
penetrate the membrane bilayer; they are linked to the underlying membrane skeleton; they are
covalently fatty acid acylated with palmitate. While the Rh antigenic reactivity is unique to
human erythrocytes, the Rh polypeptides have been isolated from erythrocytes of diverse species
and are thought to be fundamental components of all mammalian erythrocyte membranes. The
functional role of the Rh polypeptides remains undefined, but a role in the organization of
membrane phospholipid is suspected.
CLINICAL RECOGNITION OF Rh
The Rh antigens are one of the most important blood group systems in clinical and
transfusion medicine. The Rh antigen was first described in 1939 by Levine and
Stetson, who identified a young mother recently delivered of a stillborn infant. The
baby had succumbed to intrauterine hemolysis, then a disease of unknown cause [1].
The mother was herself anemic and received a transfusion with blood from her
husband, who was ABO-compatible. She had an immediate transfusion reaction, and
the investigators postulated that she had developed antibodies to a substance on the
surface of her infant's erythrocytes, which was inherited from the father. Presumably
the antibodies had crossed the placenta, causing the infant's death.
The presence of a new and pathological antibody was confirmed; the patient's serum
agglutinated the father's erythrocytes and cells from 80 of 104 random donors. At the
same time, Landsteiner and Wiener were independently seeking evidence of blood
group antigenic variations in several non-human species and had raised rabbit antibod-
ies to erythrocytes from rhesus monkeys [2]. These anti-rhesus antisera were found to
react with human erythrocytes with the same specificity as the antiserum from Levine
and Stetson's patient. The membrane antigen was therefore named "Rhesus factor" or
"Rh." Ironically, the similarity in cell specificity was subsequently found to result from
a different antigen named, in honor of Landsteiner and Wiener, "LW."
461
Copyright © 1990 by The Yale Journal of Biology and Medicine, Inc.
All rights of reproduction in any form reserved.
AGRE ET AL.
TABLE 1
Abbreviated Nomenclature of Rh Antigens'
Fisher Race Weiner
Rosenfield (CDE) (Rh-Hr)






Rh serology is exceedingly complex, and two conflicting genetic theories, which are
still not resolved, were put forth by early investigators. This problem has led to the
development of different nomenclatures, which are often confusing (refer to Table 1).
The theory proposed by Wiener postulates that different Rh antigens reside upon a
single molecule, which is the product of a complex gene [3]. The theory proposed by
Fisher and Race postulates that multiple distinct antigens exist (referred to as D, C, c,
E, and e), which are the products of multiple closely linked genes [4]. Approximately
85 percent of the general population have the major Rh antigen (D) and are referred to
as "Rh-positive" (genetically DD or Dd), while 15 percent of the population are
"Rh-negative" (dd); the latter are, of course, completely normal. While the d pheno-
type is recognized by the lack of D, no d antigen has actually been detected
serologically. The C and c antigens and the E and e antigens are found on all normal
Rh-positive and -negative erythrocytes.
No method of directly assessing the Rh genotype of an individual has been
developed, but the frequencies of the different Rh antigens have been established in
different racial and ethnic groups (Table 2). Such information permits estimation of a
"most likely" genotype, and this genotype can be further established by studying other
family members. For example, an individual whose blood reacted with antibodies to C,
c, D, and e may be genetically CDe/ce (Rl/r) or CDe/cDe (R'/R0). The former would
be more likely among whites and Asians; the latter would be more likely among blacks.
The genes encoding the D, C, c, E, and e antigens are inherited en bloc with no
crossing over during meiosis. Thus an individual with the haplotype CDe/cDE (R1/R2)
could pass on CDe (R1) or cDE (R2) to his progeny but could not pass on CDE (RZ)
or cDe (R°).
BIOCHEMICAL BASIS OF THE Rh ANTIGEN
Despite large clinical importance, the membrane structural components of the Rh
antigen remain incompletely defined. A series of investigations, beginning in the late
1960s, identified a relationship between Rh and lipid [5]. Several peculiarities of Rh
made it resistant to traditional biochemical analysis. Rh immune globulin fails to give a
specific reaction with membrane components on immunoblots or with detergent-
solubilized membranes. Membrane proteins from Rh-positive and -negative erythro-
cytes appear identical when studied with traditional electrophoresis methods. Moreover,




Selected Rh Gene Frequenciesa
Frequency
Symbol CDE Whites Blacks Asians
R' CDe 0.41 0.10 0.55
r cde 0.39 0.15 0.10
R2 cDE 0.14 0.10 0.35
R° cDe 0.03 0.60 <0.01
RZ CDE <0.01 <0.01 <0.01
aDerived from [35]
THE Rh POLYPEPTIDES
A major advance in the molecular understanding of the Rh antigens was provided by
two European groups who independently discovered the Rh polypeptides in 1982 [6,7].
As will be explained, the "Rh polypeptides" and "Rh antigens" are not synonyms,
since the Rh polypeptides are core components of the antigenic complex, but by
themselves are devoid of the immunoreactivity which defines the Rh antigens.
The Rh polypeptides were first identified by labeling intact erythrocytes with 1251. A
membrane protein of approximately 30,000 daltons was avidly labeled on the surface
of Rh-positive erythrocytes and more weakly on Rh-negative erythrocytes. Rh immune
globulin was added to the membranes, and the immune complex was solubilized in
detergent and isolated. Unlike core components of other blood group antigens, the Rh
polypeptide contains no detectable carbohydrate [8]. The Rh polypeptide also was
found to be entirely linked to the spectrin-actin membrane skeleton [9,10]. This latter
observation explains the long-recognized finding that Rh-specific IgG fails to fix
complement, and the Rh antigen-antibody complexes are unable to diffuse in the plane
of the lipid bilayer. These phenomena presumably result from physical constraints
upon the Rh antigens at the cell surface by the intracellular spectrin-actin membrane
skeleton. IgG can only activate complement when antigens are clustered at a critical
distance from one another. Linkage of the Rh antigen to the underlying membrane
skeleton prevents this process. Moreover, while the Rh polypeptide was found to be
entirely restricted to the membrane bilayer, it survived proteolytic digestions at either
the inner or outer face of the bilayer [11]. Taken together, these observations are
strong evidence that the Rh polypeptides are core components of the Rh antigens.
Rhnull PHENOTYPE
A rare phenotype known as Rh.ull has been recognized since the early 1970s [12].
Rhnuil patients suffer chronic mild hemolytic anemia. Rhnull erythrocytes contain no
detectable Rh antigens (no D, C, c, E, or e), and, when transfused with Rh-negative
blood, the patients develop antibodies to c or e. The Rh..,, phenotype is heterogeneous;
some patients appear to lack Rh-specific genes, whereas others carry Rh genes but fail
to express Rh antigens.
Rhnull erythrocytes show several phenotypic abnormalities, including abnormal
stomatocytic morphology (cup-shaped rather than disc-shaped erythrocytes), abnor-
mal cation transport [13,14], and abnormal membrane phospholipid organization with
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increased aminophospholipid in the outer leaflet of the bilayer [15]. Employing an
antibody raised in rabbits to the denatured Rh protein, immunoblots of erythrocyte
membranes from common Rh phenotypes were found to give a specific reaction with
the Rh polypeptides, whereas Rhnull membranes failed to react [16]. Also, Rh
serological reactivity is known to be destroyed by sulfhydryl oxidants. Employing a
sulfhydryl probe, two membrane proteins of 34,000 and 32,000 daltons (presumably
Rh polypeptides) were labeled in all erythrocyte membranes except those from Rhnull
individuals [ 17]. While the Rhnull membranes invariably lack the Rh polypeptide, other
polypeptides are also deficient in these membranes [18]. It is very likely that a complex
of several mutually dependent membrane proteins are expressed together with the Rh
polypeptide, a hypothesis termed the "Rh cluster" [19].
PURIFIED Rh POLYPEPTIDE
Methods for purifying the Rh polypeptide were developed, employing either immu-
nological or non-immunological methods. Large-scale immunoprecipitations followed
by preparative sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) [20] or large-scale separations employing hydroxylapatite chromatography,
gel filtration, and preparative SDS-PAGE [11] resulted in identical, pure proteins of
approximately 30,000 daltons. The serological reactivity which defines the Rh antigens
was totally lost during the purifications, however, presumably due to alteration of
conformation or loss of additional components of the Rh antigen.
Determination of N-terminal amino acid sequence from immunoprecipitated and
from chromatographically isolated Rh polypeptides yielded the same unique sequence
[21-23]. Moreover, the N-terminal amino acid sequences of the Rh polypeptides
isolated from Rh-positive and Rh-negative erythrocytes were identical [23]. Neverthe-
less, two-dimensional iodopeptide analysis of the proteins after digestion in chymo-
trypsin demonstrated a polymorphism which was specific for the Rh polypeptide
isolated from Rh-positive membranes, confirming that the Rh polypeptide is linked to
the expression of Rh antigenic phenotype. Calculating back from recovery, it was
estimated that 60,000 Rh polypeptides exist per cell. It is likely that the Rh polypep-
tides exist naturally as a complex of multiple subunits [11,19]; nevertheless, this
number is compatible with the known number of Rh D antigens per cell, approximately
20,000 [24].
COMPLEXITIES
The Rh polypeptides are now recognized to be more than a single molecular species.
Employing human antisera specific for Rh D, a protein of approximately 30,000
daltons was immunoprecipitated, whereas antisera against c or E consistently brought
down a slightly larger protein [25]. When Rh D, c, and E polypeptides were compared
by two-dimensional iodopeptide analyses, the polypeptides were found to be strikingly
similar. The c and E preparations were identical except for a single iodopeptide,
whereas the D preparation was approximately 60 percent identical to c and E [26].
These differences confirmed that the Rh polypeptides associated with the different Rh
phenotypes were similar but non-identical; these differences may result from expres-
sion of Rh polypeptides from different D, c, and E genes. Alternatively, these variations
may represent variant splicing of mRNA from a single Rh gene. Nevertheless, the
issue is as yet unresolved. While three distinct Rh polypeptides have been identified so
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far, there may be several others, such as polypeptides corresponding to the Rh C and e
antigens. The existence of a Rh d polypeptide can neither be confirmed nor refuted.
The Rh antigen may be a complex of Rh polypeptides and additional components. In
addition to the 30,000 dalton Rh polypeptide, monoclonal antibodies to D immunopre-
cipitated a hazy protein of molecular weight ranging from 45,000-100,000 daltons.
This larger protein bears polylactosaminoglycan-type carbohydrate and was initially
thought to represent glycosylated Rh polypeptides [25]. Determination of N-terminal
amino acid sequence of the glycosylated Rh protein demonstrated a unique sequence,
which was approximately 50 percent homologous with the N-terminal Rh polypeptide
sequence [ 18], suggesting duplication and divergent evolution of an ancestral Rh gene.
Thus a family of Rh proteins exists.
Rh AND LIPID
Early studies demonstrated a relationship between membrane phospholipid and Rh
serological reactivity, although the specificity was unclear [5]. Rh serological reactiv-
ity could be extracted from membranes with alcohol, but it was restored by addition of
exogenous phospholipids. Other investigators noted that Rh serological reactivity was
destroyed by phospholipases [27]. Moreover, the non-immune purifications were made
especially difficult by the unusually hydrophobic nature of the Rh polypeptide. Recent
investigation employing sequential digestions with phospholipase A2 followed by
trypsin resulted in degradation ofD but not c or E Rh polypeptides [28]. No proteolytic
degradation of any Rh polypeptides was seen without the phospholipase digestion.
When mature erythrocytes are incubated with radiolabeled palmitic acid (a satu-
rated 16 carbon fatty acid), there occurs a dramatic labeling of approximately six
erythrocyte membrane proteins of undetermined identities. Of these, the most abun-
dantly labeled is a 30,000 dalton membrane protein, which can be immunoprecipitated
with anti-Rh(D). Fatty acid acylation of the Rh polypeptide appears to be the result of
covalent thioesterification of the fatty acid on to free sulfhydryl groups within the Rh
polypeptide. This fatty acid acylation is post-translational, since mature mammalian
erythrocytes contain neither a nucleus nor endoplasmic reticulum and have negligible
protein synthesis [29]. While these studies confirmed a relationship between Rh
polypeptides and lipid, it remains uncertain whether covalently attached or adjacent
lipid is necessary for expression of Rh antigenic reactivity or whether the fatty acids
are simply supporting structures.
NON-HUMAN Rh POLYPEPTIDES
While the Rh antigen was mistakely named for the rhesus monkey, Rh antigenic
reactivity is restricted to human erythrocyte membranes. Development of the non-
immunological method for purification of Rh polypeptides permitted the isolation of
putative analogs to the Rh polypeptides from the erythrocytes of diverse species.
Erythrocytes from monkey, cow, cat, and rat were each found to contain polypeptides
that were biochemically very similar to human Rh polypeptides [30]. When studied by
two-dimensional iodopeptide analysis, it was determined that the non-human Rh
analogs appeared between 30 and 60 percent identical to the mixture of human Rh
D + c + E polypeptides. Curiously, two iodopeptides were conserved among all
species, consistent with highly conserved functionally important domain(s); however,
the iodopeptide which could be labeled at the surface of the erythrocyte membrane was
found only in the human preparations. Thus, while it is likely that the Rh polypeptide is
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of fundamental physiological importance to membrane integrity, the surface determi-
nants needed for Rh antigenic reactivity are probably unrelated to the physiological
role.
FUNCTIONAL ROLE OF Rh POLYPEPTIDES
The roles of the Rh antigens and Rh polypeptides in normal membrane physiology
remain unresolved. The Rhn.., phenotype indicates that total lack of Rh antigens and
polypeptides results in a distinct but clinically mild disorder. The constellation of
abnormal cell shape, abnormal cation transport activity, and abnormal phospholipid
distribution suggests that the Rh polypeptide may play a structural role in the
organization of membrane phospholipids. This effect may result from participation of
the Rh polypeptide in active membrane phospholipid translocation [31,32], or it may
result from a passive contribution to membrane phospholipid organization by providing
a structural restraint to membrane phospholipid mobility.
A structural role for Rh has also been suggested by the linkage of abnormal
erythrocyte morphology and Rh phenotype in a subset of hereditary elliptocytosis
families. This linkage is now recognized to result from the close chromosomal location
of genes encoding structural protein 4.1 and Rh [33,34].
The Rh gene(s) have not yet been isolated and sequenced. With the existing amino
acid sequence and antibody probes, however, it is very likely that this work will soon be
accomplished. Once cloned, the primary amino acid sequence may reveal homology
with a previously characterized polypeptide, and plausible biological roles for Rh may
be uncovered. Alternatively, the isolated Rh cDNAs may be expressed after in vitro
mutagenesis to remove sites of fatty acid acylation or after other modifications. Also,
the existance of Rh polypeptide in non-erythroid tissues may be systematically
evaluated. In view of these anticipated events, activity in this area of biology is likely to
be of significant clinical and basic scientific interest.
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